Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03694626 · ClinicalTrials.gov registry record · NA
Objectively Diagnose and Monitor Treatment of Light Sensitivity
A NA study of Traumatic Brain Injury and Migraine, sponsored by Randy Kardon.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT03694626: Recruiting NA study of Traumatic Brain Injury and Migraine, sponsored by Randy Kardon.
NCT03694626 is a NA study of Traumatic Brain Injury and Migraine that is actively recruiting participants, run by Randy Kardon. The registered enrollment target is 120 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03694626, a NA study of Traumatic Brain Injury and Migraine, is actively recruiting participants, sponsored by Randy Kardon.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to provide a new framework for diagnosing and monitoring treatment of light sensitivity and headache by objective measurement of facial features, pupil responses, retinal electrical responses and autonomic nerve responses to light.
Primary Outcome
Hand held pupillography/videography, electroretinogram, and electrophysiology measurements are correlated to develop of an objective biological marker of light sensitivity.
Conditions Studied
Interventions
- DEVICE Pupillography
- DEVICE Ocular Coherence Tomography (OCT)
- DEVICE Wrist-watch sensor device
- DEVICE Videography
- DEVICE Electrophysiology
Study Locations (1)
Iowa
- University of Iowa Health Care - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2019-07-11 |
| Est. Completion | 2028-01-01 |
| Phase | NA |
What NCT03694626 shows while recruiting
NCT03694626 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (57% lower).
The record links to 3 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 5 interventions - of which Pupillography is the first listed.
NCT03694626 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT03694626 about?
NCT03694626 is a clinical study titled "Objectively Diagnose and Monitor Treatment of Light Sensitivity". The purpose of this project is to provide a new framework for diagnosing and monitoring treatment of light sensitivity and headache by objective measurement of facial features, pupil responses, retinal electrical responses and autonomic nerve responses to light.
What is the current status of trial NCT03694626?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2019-07-11. Estimated completion is 2028-01-01.
What conditions does trial NCT03694626 study?
This clinical trial studies the following conditions: Traumatic Brain Injury, Migraine, Photophobia.
What interventions are being tested in trial NCT03694626?
The interventions under investigation include: Pupillography (DEVICE), Ocular Coherence Tomography (OCT) (DEVICE), Wrist-watch sensor device (DEVICE), Videography (DEVICE), Electrophysiology (DEVICE).
Who is sponsoring clinical trial NCT03694626?
This trial is sponsored by Randy Kardon, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03694626 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03694626's enrollment target sits among peer trials
120 56th of 171 higher than 113 of 171 other Traumatic Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
tPBM in Older Adults With Traumatic Brain Injury
RECRUITING · NA
-
Carbon Dioxide Administration and Brain Waste Clearance
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Community-based Implementation of Online EmReg
RECRUITING · NA
-
Evaluation of the Abbott i-STAT TBI Biomarker Test
RECRUITING · NA
-
Long-term Brain Stimulation of the Motor Ventral Thalamus (VOP/VIM) to Improve Motor Function
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI